Nuveen Asset Management, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,404,434
-56.5%
273,513
+4.2%
0.00%
-50.0%
Q2 2023$23,904,457
+103575.5%
262,398
-24.9%
0.01%
-11.1%
Q1 2023$23,057
+23.6%
349,554
-3.1%
0.01%
+28.6%
Q4 2022$18,653
-99.9%
360,735
-12.1%
0.01%
-36.4%
Q3 2022$28,030,000
+64.8%
410,401
+9.1%
0.01%
+57.1%
Q2 2022$17,012,000
+23.9%
376,200
+42.7%
0.01%
+75.0%
Q1 2022$13,733,000
+27.6%
263,645
+2.8%
0.00%
+33.3%
Q4 2021$10,766,000
+18.2%
256,441
-3.7%
0.00%0.0%
Q3 2021$9,108,000
-56.5%
266,244
-19.6%
0.00%
-50.0%
Q2 2021$20,931,000
+84.8%
331,179
+25.5%
0.01%
+50.0%
Q1 2021$11,326,000
-26.2%
263,961
-1.7%
0.00%
-20.0%
Q4 2020$15,354,000
+86.7%
268,416
-1.5%
0.01%
+66.7%
Q3 2020$8,223,000
-7.5%
272,547
+0.1%
0.00%
-25.0%
Q2 2020$8,894,000
-8.0%
272,335
-24.5%
0.00%
-20.0%
Q1 2020$9,666,000
+62.2%
360,805
+85.4%
0.01%
+150.0%
Q4 2019$5,959,000
+27.1%
194,611
-0.0%
0.00%0.0%
Q3 2019$4,689,000
+7.5%
194,631
+13.1%
0.00%0.0%
Q2 2019$4,361,000172,1280.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders